Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMUQ390)

• Drug Name: Murepavadin Drug Info
• Synonyms: UNII-0D02GRY87Z; 0D02GRY87Z; 944252-63-5; Murepavadin [INN]; Murepavadin [USAN:INN]; Murepavadin (USAN/INN); CHEMBL3946483; Cyclo(L-alanyl-L-seryl-D-prolyl-L-prolyl-L-threonyl-L-tryptophyl-L-isoleucyl-(2S)-2,4-diaminobutanoyl-L-ornithyl-(2R)-2,4-diaminobutanoyl-(2S)-2,4-diaminobutanoyl-L-tryptophyl-(2S)-2,4-diaminobutanoyl-(2S)-2,4-diaminobutanoyl); RO7033877; D10957

Indication

Disease Entry	ICD 11	Status	REF
Ventilator-associated pneumonia	PK81.0	Phase 3	[1]

• Cross-matching ID:
  PubChem CID: 91824766
  CAS Number: CAS 944252-63-5
  TTD Drug ID: DMUQ390

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Pseudomonas LPS-assembly protein LptD (Pseudo lptD)	TTJZ7GF	LPTD_PSEAE	Antagonist	[1]

References

• [1] Anti-ageing pipeline starts to mature.Nat Rev Drug Discov. 2018 Sep;17(9):609-612.